Voyager Therapeutics
VYGR
52 hedge funds and large institutions have $127M invested in Voyager Therapeutics in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
9% more capital invested
Capital invested by funds: $116M → $127M (+$10.8M)
8% more funds holding
Funds holding: 48 → 52 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Partner Investment Management
San Francisco,
California
|
+$1.84M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.35M |
| 3 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$1.23M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
+$789K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$2.89M |
| 2 |
Goldman Sachs
New York
|
-$1.28M |
| 3 |
JP Morgan Chase
New York
|
-$1.05M |
| 4 |
CC
Casdin Capital
New York
|
-$623K |
| 5 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$383K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JHIU
51
Janus Henderson Investors US
Denver,
Colorado
| – | -$2.89M | -263,074 | Closed |
|
|
TC
52
TFS Capital
West Chester,
Pennsylvania
| – | -$324K | -29,468 | Closed |
|
|
AIM
53
Acrospire Investment Management
Chicago,
Illinois
| – | -$45K | -4,106 | Closed |
|
|
PCM
54
Prelude Capital Management
New York
| – | -$24K | -2,143 | Closed |
|
55
Acadian Asset Management
Boston,
Massachusetts
| – | -$23.5K | -1,735 | -98% |
|
56
Citigroup
New York
| – | -$13K | -1,174 | Closed |
|
|
PA
57
Perceptive Advisors
New York
| – | -$7K | -650 | Closed |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$68 | +5 | New |
|
VYGR Hedge Fund Activity: Q3 2016 in Review
52 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2016, worth a combined $127M — up 9.3% from $116M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VYGR positions and 6 closed out — a net gain of 4 holders — while 20 added to existing stakes and 11 trimmed.
The largest buyer was Partner Investment Management, adding an estimated $1.84M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $2.89M sold.
- 52 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2016, up from 48 in Q2 2016.
- Funds reported $127M of Voyager Therapeutics stock for Q3 2016, up 9.3% quarter-over-quarter.
- 10 funds opened new Voyager Therapeutics positions in Q3 2016 and 6 closed out, a net change of +4 holders.
- The largest Voyager Therapeutics buyer in Q3 2016 was Partner Investment Management, an estimated $1.84M added.
- The largest Voyager Therapeutics seller in Q3 2016 was Janus Henderson Investors US, an estimated $2.89M sold.
Based on aggregated 13F filings for Q3 2016.